E. Feist

Type de document

Co-auteur

F. Spertini

A. Sleight

H. Schulze-Koops

E.J. Schiffrin

T. Schaeverbeke

J. Rech

J. Morel

T. Martin

P. Lamprecht

I. Kötter

B. Hellmich

M.A. Hamidou

E. Hachulla

C. Gabay

B. Fautrel

D.S. Courvoisier

Source

Serveur académique Lausannois (1)

Mot-clé

administration (1) thérapie (1) sécurité (1) protéine (1) gestion (1) dose (1) dosage (1) maladie (1) adulte (1) procès (1) index (1) jeune (1) Dose-response relationship (1) Treatment (1) Juvenile (1) Week (1) Values (1) Therapeutics (1) State, The (1) Signs and symbols (1) Signs and signboards (1) Rheumatoid arthritis in children (1) Prednisone (1) Political science (1) Peptides (1) Patients (1) Neuropathy (1) Management (1) Human beings (1) Injections, Hypodermic (1)

Documents écrit par E. Feist (1) | parle de E. Feist (2)

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease.

C. Gabay et al.